Michael Siluk/UCG/Universal Images Group via Getty Images
- Bernie Sanders said the CEO of Novo Nordisk will testify on the cost of Ozempic and Wegovy.
- Lars Jørgensen will appear before the Senate Committee on Health, Education, Labor, and Pensions.
- Sanders, who chairs the committee, said the hearing would focus on the "outrageously high cost" of the drugs.
US Senator Bernie Sanders has announced that the CEO of Danish drug company Novo Nordisk will testify on the high cost of the weight-loss drugs Ozempic and Wegovy.